Skip to content

Insider · CIK 0001991365

Nina Armagno

director

Files at RKLB (Rocket Lab USA, Inc.). First filing Feb 6, 2025, latest Dec 23, 2025.

In brief

Nina Armagno files SEC Form 4 as director at RKLB (Rocket Lab USA, Inc.). Since Feb 6, 2025, Nina Armagno has reported 0 open-market buys worth $0 and 2 open-market sells worth $2.1M, the latest filed on Dec 23, 2025.

A track record needs three past buys with six months of prices behind them; Nina Armagno has 0, so none is measured yet.

The newest scored trade: sold $1.9M of RKLB on Dec 19, 2025, filed Dec 23, 2025, scored 40 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $1.9M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $2.1M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RKLB: Rocket Lab USA, Inc.

RKLBOct 12, 2026 · close 65.71

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
RKLBsell 610b5-1
Rocket Lab USA, Inc.
$1.9M
27,314 shares
-20%+331% from low0% from high
36Weak
RKLBsell 2
Rocket Lab USA, Inc.
$236k
10,000 shares
-7%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Dec 19, 2025 RKLB
Rocket Lab Corporation
27,314
0.01% of outstanding
$1.6MDec 19, 2025none
Dec 11, 2024 RKLB
ROCKET LAB USA, INC.
10,000
0.00% of outstanding
$236kDec 11, 2024none

Transactions

Every row this insider has filed, 13 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 20, 2026RKLB
Rocket Lab USA, Inc.
AGrant or award
Common Stock
+2,482$0.00$0111,422May 22, 2026
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-200$60.99$12k136,054Dec 23, 2025
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-1,200$62.76$75k134,854Dec 23, 2025
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-1,200$63.51$76k133,654Dec 23, 2025
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-2,700$64.75$175k130,954Dec 23, 2025
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-2,700$65.66$177k128,254Dec 23, 2025
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-500$66.75$33k127,754Dec 23, 2025
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-1,906$68.32$130k125,848Dec 23, 2025
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-4,462$69.50$310k121,386Dec 23, 2025
Dec 19, 2025RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock10b5-1
-12,446$70.18$873k108,940Dec 23, 2025
Aug 27, 2025RKLB
Rocket Lab USA, Inc.
AGrant or award
Common Stock
+3,960$0.00$0136,254Aug 29, 2025
Dec 11, 2024RKLB
Rocket Lab USA, Inc.
SOpen-market sale
Common Stock
-10,000$23.63$236k132,294Feb 6, 2025
Oct 30, 2023RKLB
Rocket Lab USA, Inc.
AGrant or award
Common Stock
+81,943$0.00$081,943Nov 1, 2023

Questions about Nina Armagno

Answered from the filings on this page, as of the latest one.

Is Nina Armagno buying or selling?

In the last 12 months Nina Armagno reported 0 open-market buys worth $0 and 1 open-market sell worth $1.9M on SEC Form 4; the latest was sold $1.9M of RKLB on Dec 19, 2025. Grants, option exercises and tax withholding are not counted.

How did Nina Armagno's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nina Armagno has 0.

Where does Nina Armagno file Form 4?

Nina Armagno has filed Form 4 at RKLB (Rocket Lab USA, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nina Armagno: insider trades and track record | InsiderTell